Stock AnalizGE HealthCare Technologies (GEHC) earnings for the quarter ended September 2026: EPS beats estimates
GE HealthCare Technologies reported results for the quarter ended September 2026 on October 28, 2026. Adjusted earnings per share came in at $1.34 against the analysts’ average forecast of $1.20, a beat of 11.3%.
Revenue for the quarter was $5.51 billion, up 7.2% from $5.14 billion in the same quarter a year earlier.
The market’s verdict: the stock rose 6.6% on the first trading day after the report.
The last four quarters
GE HealthCare Technologies has beaten the analysts’ EPS forecast in 3 of the last 4 quarters.
| Quarter | EPS | Forecast | Surprise | Revenue growth | Price reaction |
|---|---|---|---|---|---|
| Sep 2026 | $1.34 | $1.20 | +11.3% | +7% | +6.6% |
| Jun 2026 | $1.13 | $1.04 | +9.1% | — | +9.1% |
| Mar 2026 | $0.99 | $1.05 | −5.7% | +7% | −11.2% |
| Dec 2025 | $1.44 | $1.40 | +3.0% | +7% | +4.5% |
What comes next
Analysts expect EPS of $1.56 for the next quarter on average and $5.02 for the fiscal year ending December 31, 2026.
The average analyst price target is $87.85, 6% above the current price of $83.02.
Valuation and score
GE HealthCare Technologies scores 2.4 out of 5 overall on Stock Analiz (average), trades at a trailing P/E of about 17.5, and its intrinsic value under moderate assumptions is about 26% below the current market value. Full GE HealthCare Technologies analysis with 10 years of financials
Frequently asked questions
What was GE HealthCare Technologies’s EPS for the quarter ended September 2026?
$1.34 adjusted per share, against an analyst consensus of $1.20.
How much revenue did GE HealthCare Technologies report?
$5.51 billion, up 7.2% year over year.
More
This report was written automatically from the published numbers within hours of the release. It is information, not investment advice.